Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAM8-22 as a Surrogate Model of Non-histaminergic Itch
NCT06036589Completed
- Sponsor
- Aalborg University
- Start
- Mar 2022
- Primary completion
- May 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of BAM8-22 and cinnamaldehyde in pruritus (2 arms), sponsored by Aalborg University. Primary endpoints: Superficial blood perfusion up to 10 minutes, Warm Detection Threshold up to 10 minutes and 8 more. Started Mar 2022; status: completed.
02
Drugs
BAM8-22cinnamaldehyde
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT06036589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06036589.